US Patent Issued to Universitat Pompeu Fabra on Sept. 15 for "Treatment and/or diagnosis of a cancer type characterized by expressing zinc transporter ZIP4" (Spanish Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,245, issued on Sept. 15, was assigned to Universitat Pompeu Fabra (Barcelona, Spain).

"Treatment and/or diagnosis of a cancer type characterized by expressing zinc transporter ZIP4" was invented by Pilar Rivera Gil (Barcelona, Spain), Ruben Vicente Garcia (Barcelona, Spain) and Ruixue Xu (Barcelona, Spain).

According to the abstract* released by the U.S. Patent & Trademark Office: "Treatment and/or diagnosis of a cancer type characterized by expressing zinc transporter ZIP4. The present invention is directed to nanocarriers functionalized with a ligand capable to bind to the extracellular domain of zinc transporter ZIP4, for use in the treatment and/or diagnosis of a cancer type...